OR WAIT null SECS
March 02, 2014
China's regulatory and compliance environment is set to change as the government declares a crackdown on bribery scandals.
February 11, 2014
NSF-IPEA now can provide excipient auditing and certification.
January 31, 2014
Regis Technologies passes a recent FDA audit with no Form 483 observations.
December 06, 2013
FDA cites cGMP violations and data-integrity issues and raises concerns over the company's ability to implement a robust and sustainable quality system.
November 04, 2013
Novasep?s European manufacturing sites in France and Germany pass FDA audits.
August 21, 2013
Companies exhibit developments for pharmaceutical packaging to meet needs, such as e-pedigree and inspection requirements.
June 11, 2013
FDA cites cGMP violations of finished pharmaceuticals at the company's facilities in Marion North Carolina and Jayuya, Puerto Rico.
June 05, 2013
The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.
May 28, 2013
Company receives notice from FDA for not fully investigating foreign particles in APIs and finished products made from its facility in Ingelheim am Rhein, Germany.
April 11, 2013
Company is notified of GMP violations at facility in Catania, Italy.